Figure 1

(a) Hemotoxylin and Eosin-stained liver section of control rat (b) Liver section of CCl 4 treated rats showing marked fatty changes, cellular hypertrophy, degeneration of the lobular architecture and blood vessel congestion with disturbed epithelium (c) Liver section of CCl 4 + SAME showing less injuries (d) Liver section of CCl 4 + Silymarin showing less injuries..